The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss ...
By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U.S. in the first full week after its launch in an encouraging start to the oral weight-loss ...
Novo Nordisk stock moved higher after oral Wegovy logged over 18,000 first-week prescriptions, with Goldman Sachs boosting sentiment via a Buy rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback